Bio-Techne
TECH
#2076
Rank
C$12.58 B
Marketcap
C$80.79
Share price
-0.29%
Change (1 day)
-22.08%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.53 Billion

According to Bio-Techne's latest financial reports the company's total debt is C$0.53 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-06-30C$0.57 B-4.74%
2023-06-30C$0.60 B43.49%
2022-06-30C$0.41 B-19.48%
2021-06-30C$0.52 B-11.44%
2020-06-30C$0.58 B-11.01%
2019-06-30C$0.66 B48.35%
2018-06-30C$0.44 B-0.18%
2017-06-30C$0.44 B261.79%
2016-06-30C$0.12 B28.44%
2015-06-30C$96.1 M595.66%
2014-06-30C$13.81 M
2006-06-30C$14.9 M-17.84%
2005-06-30C$18.14 M-14.07%
2004-06-30C$21.11 M-8.25%
2003-06-30C$23.01 M-15.89%
2002-06-30C$27.36 M-4.61%
2001-06-30C$28.68 M-2.09%
2000-06-30C$29.29 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Thermo Fisher Scientific
TMO
C$48.81 B 8,944.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
C$1.90 B 253.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$26.24 B 4,762.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
C$23.06 B 4,173.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
C$2.91 B 439.25%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
C$28.50 B 5,182.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$4.1 M-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA